Alma Lasers (Isreal) and AbbVie Inc. (Ireland) are Leading Players in the Medical Aesthetics Market
The global medical aesthetics market is projected to reach USD 23.4 billion by 2027 from USD 13.9 billion in 2022, at a CAGR of 11.0% from 2022 to 2027. The market is expanding as a result of factors like the rising popularity of minimally invasive and noninvasive aesthetic procedures, the rising popularity of aesthetic procedures among geriatric patients, the accessibility of technologically advanced and user-friendly products, and the rising demand for aesthetic treatments among men. The availability and acceptance of alternative beauty and cosmetic goods, which are becoming more widely available, are, however, limiting the expansion of this market, as are the clinical risks and consequences connected with medical aesthetic operations.
The medical aesthetics business is very competitive, with both established companies and newcomers competing for the same market share. As of 2021, the key players operating in the global medical aesthetics market are Advanced Energy Industries, Alma Lasers (Isreal), ANIKA THERAPEUTICS, INC. (US), AbbVie Inc. (Ireland), Cynosure (US), Cutera (California), and El.En. S.p.A.(Italy), Inmode Ltd.(Israel), Lumenis Be Ltd. (Israel), Fotona (US), Galderma (Switzerland), Johnson & Johnson Services, Inc(US), Merz Pharma (US), Medytox. (South Korea), Sientra, Inc.(US), Huadong Medicine Co., Ltd (China), Bausch Health Companies Inc.(Canada), Candela Corporation. (US), Venus Concept(Canada), aeroloase(US), Sciton.(US), and Bohus BioTech AB(US) among others.